List view / Grid view
At ELRIG’s Drug Discovery 2025, Drug Target Review spoke with the teams turning big ideas into usable tools – automation, AI and biology – that help scientists work smarter.
Automation now plays a central role in discovery. From self-driving laboratories to real-time bioprocessing, this report explores how data-driven systems improve reproducibility, speed decisions and make scale achievable across research and development.
Scientists have developed an ingestible, light-emitting capsule that can detect life-threatening intestinal blood flow problems in their earliest stages. The device could offer doctors a faster and less invasive way to diagnose acute mesenteric ischaemia.
Researchers at UC San Diego have discovered a graphene-based technology that accelerates the maturation of human brain organoids, offering a safer, non-invasive way to model diseases like Alzheimer’s.
James Atwood, COO of Opentrons, shares how accessible lab automation is helping research teams tackle tighter budgets, faster timelines and complex discovery workflows.
In this interview with Jose-Manuel Collados, learn how ABB's strategic partnerships and automation technology are improving lab efficiency, enhancing precision and ultimately speeding up the development of life-saving treatments.
Researchers from China have formulated a robotics system that can access areas in the lung non-invasively before cancer diagnosis.
A report has found that increased investment in drug discovery will help the demand for personalised medicine, encouraging the growth of the liquid handling market.
An automated intracellular sensing system could provide an efficient approach to reveal the cellular characteristics of disease progression.
A capsule that tunnels through mucus in the gastrointestinal tract could be used to orally administer large protein drugs such as insulin.
30 June 2022 | By Brooks Automation
Watch this on-demand webinar to learn how collaborative robots are improving accuracy and efficiency in today’s laboratories.
A recent paper highlights how tiny robots with living parts can be designed to effectively deliver drugs to body tissues.
In this latest episode, we discuss how small molecule discovery can be automated and how this process saves researchers time and money.
View Drug Target Review's new infographic on the use of AI and informatics within early therapeutic development here.
Nanoengineers have developed a high-throughput bioprinter that 3D prints at record speed, potentially accelerating drug development.
